当前位置:首页 - 行情中心 - 太龙药业(600222) - 财务分析 - 现金流量表

太龙药业

(600222)

  

流通市值:42.18亿  总市值:42.18亿
流通股本:5.59亿   总股本:5.59亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金770,693,026.78288,022,291.481,656,679,498.411,197,876,027.92
  收到的税费返还--0-
  收到其他与经营活动有关的现金5,131,279.372,178,580.049,618,055.518,407,148.59
  经营活动现金流入小计775,824,306.15290,200,871.521,666,297,553.921,206,283,176.51
  购买商品、接受劳务支付的现金585,004,398.58332,668,591.721,107,253,003.49927,180,790.99
  支付给职工以及为职工支付的现金147,807,129.6279,723,259.28303,863,376.69229,968,331
  支付的各项税费42,314,379.8729,115,948.6870,648,803.4452,785,570.54
  支付其他与经营活动有关的现金60,715,384.2546,345,709.42137,374,363.0885,337,525.16
  经营活动现金流出小计835,841,292.32487,853,509.11,619,139,546.71,295,272,217.69
  经营活动产生的现金流量净额-60,016,986.17-197,652,637.5847,158,007.22-88,989,041.18
二、投资活动产生的现金流量:
  收回投资收到的现金100,000,000100,000,000130,076,002.79124,219,785.66
  取得投资收益收到的现金39,259.7339,259.7338,799,799.0522,993,898.04
  处置固定资产、无形资产和其他长期资产收回的现金净额6,855-68,62160,426
  处置子公司及其他营业单位收到的现金净额--88,813.011,582,224
  收到的其他与投资活动有关的现金--00
  投资活动现金流入小计100,046,114.73100,039,259.73169,033,235.85148,856,333.7
  购建固定资产、无形资产和其他长期资产支付的现金4,963,046.053,126,238.9521,122,400.0812,061,211.87
  投资支付的现金--147,750,00047,750,000
  投资活动现金流出小计4,963,046.053,126,238.95168,872,400.0859,811,211.87
  投资活动产生的现金流量净额95,083,068.6896,913,020.78160,835.7789,045,121.83
三、筹资活动产生的现金流量:
  取得借款收到的现金635,400,000530,400,0001,038,887,940.49830,018,450.51
  收到其他与筹资活动有关的现金632,400,000469,500,000883,832,141.55760,975,349.61
  筹资活动现金流入小计1,267,800,000999,900,0001,922,720,082.041,590,993,800.12
  偿还债务支付的现金460,895,381.75298,805,891.771,240,412,873.44880,682,009.99
  分配股利、利润或偿付利息支付的现金35,769,406.9424,066,432.1450,763,605.8439,608,231.06
  支付其他与筹资活动有关的现金770,242,761.74623,114,351.34646,910,152.66495,939,310.12
  筹资活动现金流出小计1,266,907,550.43945,986,675.251,938,086,631.941,416,229,551.17
  筹资活动产生的现金流量净额892,449.5753,913,324.75-15,366,549.9174,764,248.95
五、现金及现金等价物净增加额35,958,532.08-46,826,292.0531,952,293.09174,820,329.6
  加:期初现金及现金等价物余额175,845,198.94175,845,198.94143,892,905.85143,892,905.85
  期末现金及现金等价物余额211,803,731.02129,018,906.89175,845,198.94318,713,235.45
补充资料:
  净利润13,160,737.81-65,867,565.55-
  资产减值准备2,106,521.39-5,615,222.38-
  固定资产和投资性房地产折旧22,194,101.69-46,100,998.43-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧22,194,101.69-46,100,998.43-
  无形资产摊销2,382,961.86-5,894,001.28-
  长期待摊费用摊销4,676,027.44-8,760,944.66-
  处置固定资产、无形资产和其他长期资产的损失--23,974-
  固定资产报废损失-1,419.72-134,784.03-
  公允价值变动损失-8,595,884.71--1,399,054.4-
  财务费用27,737,224.81-58,981,205.42-
  投资损失2,958,840.33-154,766.82-
  递延所得税1,084,721.85-7,916,119.87-
  其中:递延所得税资产减少-114,602.69-4,895,650.98-
    递延所得税负债增加1,199,324.54-3,020,468.89-
  存货的减少-120,266,170.53-9,944,921.38-
  经营性应收项目的减少-6,675,276.51--218,708,643.37-
  经营性应付项目的增加-3,199,312.34-23,219,412.38-
  现金的期末余额211,803,731.02-175,845,198.94-
  减:现金的期初余额175,845,198.94-143,892,905.85-
  现金及现金等价物的净增加额35,958,532.08-31,952,293.09-
公告日期2026-08-282026-04-302026-04-152025-10-30
审计意见(境内)标准无保留意见
TOP↑